ABOUT US
Our Story
Heart disease is rarely diagnosed in the early stages due to limitations of traditional diagnostic tools and lack of noticeable symptoms
77 to 82 percent of EKG screenings are false positives, while 6 to 7 percent are false negatives (https://www.sciencedaily.com/
releases/2009/11/091116103435.htm) A significant percentage of those who had cardiac catheterization or angiograms do not have atherosclerosis (Low Diagnostic Yield of Elective Coronary Angiography | NEJM)
77 to 82 percent of EKG screenings are false positives, while 6 to 7 percent are false negatives (https://www.sciencedaily.com/releases/2009/11/091116103435.htm) A significant percentage of those who had cardiac catheterization or angiograms do not have atherosclerosis (Low Diagnostic Yield of Elective Coronary Angiography | NEJM)
Definite diagnosis of coronary microvascular disease requires invasive procedures (https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4699946/)
Definite diagnosis of coronary microvascular disease requires invasive procedures (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699946/)
Early detection of heart disease can help the patient make lifestyle changes that can stop and reverse its progression
So, when our founders, Chris Coates and Brent Boyle, learned of how MCG™ can detect heart disease in its early stages accurately and non-invasively, they made it their mission to distribute it in the United States and help fill the gaps in assessing and improving the cardiovascular health of Americans.
Our Mission & Vision
Paving the way for healthcare professionals to extend the innovative diagnostic capabilities of the Multifunction Cardiogram™
Envisioning a future where every American enjoys objective, non-invasive, and cost-efficient cardiac health diagnostics and monitoring
We envision a future where HeartCore Health is the leading distributor of the Multifunction Cardiogram™ where every American enjoys the objective, non-invasive, and cost-efficient benefits that MCG™ offers, and where early detection of cardiac health issues is the norm, not the exception. And, through the more reliable diagnosis it provides, we see those with a heightened risk of cardiovascular disease receive appropriate care without unnecessary medication or surgeries.
What Sets HeartCore Health Apart
Early Detection through AI
Early detection is key for reversing or successfully managing any health condition, including various heart and cardiovascular diseases. The AI-driven technology that the Multifunction CardioGram™ provides makes this a possibility in those with heart disease, which could only be detected by previous diagnostic tools in its advanced stages with accuracy. This allows for timely intervention that increases the patient’s chance of stopping or reversing the progression of their disease.
Over 2 Million Patients Tested
The Multifunction CardioGram™ compares a patient’s electrocardiographic signals to the machine’s knowledge of the various forms of heart disease. It was built through a two-decade research and development period, where it learned from analyzing a database of 100,000 individuals with various common cardiac diseases. The machine was taught to recognize various forms of heart disease by testing it on 2 million individuals of varying ethnicities and of an equal male/female ratio who had their biomarkers taken to confirm their condition.
Recognized Excellence
The Multifunction Cardiogram™ has earned ISO approval and FDA 510K clearance, which clears the device to be marketed after rigorous review and approval processes. The device has also won the 2017 American Heart Association’s Heart Science Forum’s Innovative Challenge Award, which recognizes the MCG™ as the best major advancement in cardiovascular research for that year. It was also featured in the ACEP Research Forum in 2020.
Recognized Excellence
Several double-blind independent prospective clinical trials have already been conducted to validate the Multifunction Cardiogram™ in the United States, China, Germany, India, Singapore, Myanmar, and Malaysia. These studies observed that the overall accuracy of the MCG™ has a reproducible rate of over 90 percent and up to 100 percent when its results are combined with serum biomarkers.
Here are some highlights of the various meta-analyses conducted on the MCG™:
MCG™ is 3 to 5 times more accurate than conventional ECG
MCG™ is 2 to 3 times more accurate than echocardiogram
MCG™ is 2 to 3 times more accurate than nuclear, echo, ECG, and pharmacological stress tests
MCG™ can quantify the degrees of functional loss of the myocardium and its interaction with other factors
MCG™ can detect low, intermediate, and high degrees of ischemia
MCG™ is just as accurate for people with low risks as it is for people with intermediate or high risks for CAD
MCG™ is just as accurate for women as it is for men
MCG™ can predict myocardial ischemia due to post-interventional restenosis
MCG™ can predict recurrent Atrial Fibrillation post-ablation procedures
MCG™ can predict “INCIPIENT” Atrial Fibrillation or ventricular arrhythmia BEFORE being detected by conventional ECG
MCG™ can detect abnormal expression of the myocardial system that is beyond the capabilities of conventional diagnostic methods
A Focus on Comprehensive Care
The MCG™ identifies 26 indicators of cardiovascular disease through a non-invasive procedure and with the highest accuracy out of all the diagnostic methods available today. It can identify signs of developing heart failure years before it becomes clinically evident. It can detect disturbances in the heart rhythm before they even become noticeable to most patients. It can detect coronary microvascular disease, often left undetected by other technologies. And it identifies if a patient is at risk for plaque instability, which enables physicians to address it before the plaque ruptures.
The MCG™ Technology
The Multifunction Cardiogram™ revolutionizes the detection of various heart ailments. It only requires the placement of probes, similar to a resting ECG, and does not require injections for contrast or blood samples to obtain an accurate reading. Health facilities, from walk-in clinics to large hospital systems, do not need specialized areas or personnel to use them. And, as long as there is an internet connection to communicate with the MCG™’s data center, physicians can provide rapid, objective, and accurate diagnoses of heart diseases.
Let’s Get In Touch
Contact us through our contact form and we’ll get back to you as soon as we can.
Contact Us
To Learn More
Are you ready to join us in changing the field of cardiovascular diagnostics and care?
Contact us today to learn more about how you can integrate this into your healthcare services or programs.
